Vontobel Holding Ltd. Has $4.88 Million Position in HealthEquity, Inc. (NASDAQ:HQY)

Vontobel Holding Ltd. boosted its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 96.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 73,564 shares of the company's stock after buying an additional 36,085 shares during the quarter. Vontobel Holding Ltd. owned 0.09% of HealthEquity worth $4,877,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of HQY. PNC Financial Services Group Inc. boosted its stake in HealthEquity by 31.8% during the first quarter. PNC Financial Services Group Inc. now owns 13,547 shares of the company's stock valued at $913,000 after buying an additional 3,266 shares in the last quarter. AlphaCrest Capital Management LLC purchased a new stake in shares of HealthEquity during the first quarter valued at $234,000. Natixis Advisors L.P. purchased a new stake in shares of HealthEquity during the first quarter valued at $932,000. Bank of Montreal Can lifted its holdings in shares of HealthEquity by 44.5% during the first quarter. Bank of Montreal Can now owns 8,218 shares of the company's stock valued at $553,000 after purchasing an additional 2,532 shares during the last quarter. Finally, Rhumbline Advisers lifted its holdings in shares of HealthEquity by 2.2% during the first quarter. Rhumbline Advisers now owns 231,307 shares of the company's stock valued at $15,599,000 after purchasing an additional 4,880 shares during the last quarter. Institutional investors own 99.55% of the company's stock.

HealthEquity Stock Down 0.0 %

Shares of NASDAQ HQY traded down $0.02 during mid-day trading on Thursday, reaching $79.85. 487,341 shares of the company traded hands, compared to its average volume of 604,807. The company has a debt-to-equity ratio of 0.43, a quick ratio of 4.76 and a current ratio of 4.76. The stock has a market cap of $6.85 billion, a PE ratio of 124.77, a price-to-earnings-growth ratio of 1.31 and a beta of 0.53. The company's fifty day moving average is $81.05 and its two-hundred day moving average is $74.21. HealthEquity, Inc. has a fifty-two week low of $48.86 and a fifty-two week high of $84.49.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.08. The firm had revenue of $262.39 million for the quarter, compared to analyst estimates of $258.56 million. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. On average, analysts expect that HealthEquity, Inc. will post 2.12 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. BTIG Research upped their target price on HealthEquity from $100.00 to $110.00 and gave the company a "buy" rating in a report on Wednesday, March 20th. JMP Securities initiated coverage on HealthEquity in a research note on Thursday, April 4th. They issued a "mkt outperform" rating and a $101.00 price objective for the company. Bank of America increased their price objective on HealthEquity from $93.00 to $97.00 and gave the stock a "buy" rating in a research note on Wednesday, March 20th. Barrington Research reissued an "outperform" rating and issued a $100.00 price objective on shares of HealthEquity in a research note on Friday, March 22nd. Finally, Barclays increased their price objective on HealthEquity from $84.00 to $104.00 and gave the stock an "overweight" rating in a research note on Friday, February 23rd. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $96.17.

Insider Buying and Selling

In other news, Director Evelyn S. Dilsaver sold 32,500 shares of the firm's stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the completion of the transaction, the director now directly owns 32,123 shares of the company's stock, valued at approximately $2,547,032.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CEO Jon Kessler sold 33,765 shares of the stock in a transaction dated Friday, March 22nd. The shares were sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the transaction, the chief executive officer now owns 126,635 shares of the company's stock, valued at $10,106,739.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Evelyn S. Dilsaver sold 32,500 shares of the stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the completion of the transaction, the director now directly owns 32,123 shares of the company's stock, valued at approximately $2,547,032.67. The disclosure for this sale can be found here. Insiders sold a total of 71,322 shares of company stock valued at $5,682,895 over the last ninety days. 2.70% of the stock is owned by company insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.